| Nicholaos Kalathas, | |
|
112 N 7th St, Chambersburg, PA 17201-1720 | |
| (717) 267-7146 | |
| (717) 267-7728 |
| Full Name | Nicholaos Kalathas |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 14 Years |
| Location | 112 N 7th St, Chambersburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013235514 | NPI | - | NPPES |
| 102810325 0002 | Medicaid | PA | |
| 30152910 | Other | PA | AMERIHEALTH CARITAS PA - YH |
| 788489 | Other | PA | UPMC |
| 102810325 0001 | Medicaid | PA | |
| 1622617 | Other | PA | GATEWAY |
| 2879187 | Other | PA | HIGHMARK BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MT196913 (Pennsylvania) | Secondary |
| 207P00000X | Emergency Medicine | MD447758 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chambersburg Hospital | Chambersburg, PA | Hospital |
| Waynesboro Hospital | Waynesboro, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Chambersburg Hospital | 5496748303 | 27 |
| Waynesboro Hospital | 6305830936 | 28 |
News Archive
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a preclinical trial for an H7N9 Avian Influenza VLP vaccine candidate ("H7 vaccine").
Imprivata®, Inc., the employee access management company and largest provider of healthcare single sign-on (SSO), today announced that it continues to see strong demand for its OneSign Platform solution from the healthcare industry's leading organizations.
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
Hops, the flower cones used in beer-making, are also found in dietary supplements designed to help treat post-menopausal symptoms and other conditions. Scientists are now investigating whether an extract from the plant could also help fend off breast cancer.
› Verified 9 days ago
| Entity Name | Waynesboro Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821091059 PECOS PAC ID: 6305830936 Enrollment ID: O20040414001527 |
News Archive
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a preclinical trial for an H7N9 Avian Influenza VLP vaccine candidate ("H7 vaccine").
Imprivata®, Inc., the employee access management company and largest provider of healthcare single sign-on (SSO), today announced that it continues to see strong demand for its OneSign Platform solution from the healthcare industry's leading organizations.
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
Hops, the flower cones used in beer-making, are also found in dietary supplements designed to help treat post-menopausal symptoms and other conditions. Scientists are now investigating whether an extract from the plant could also help fend off breast cancer.
› Verified 9 days ago
| Entity Name | The Chambersburg Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558460428 PECOS PAC ID: 5496748303 Enrollment ID: O20040420001214 |
News Archive
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a preclinical trial for an H7N9 Avian Influenza VLP vaccine candidate ("H7 vaccine").
Imprivata®, Inc., the employee access management company and largest provider of healthcare single sign-on (SSO), today announced that it continues to see strong demand for its OneSign Platform solution from the healthcare industry's leading organizations.
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
Hops, the flower cones used in beer-making, are also found in dietary supplements designed to help treat post-menopausal symptoms and other conditions. Scientists are now investigating whether an extract from the plant could also help fend off breast cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholaos Kalathas, 760 E Washington St, Chambersburg, PA 17201-2751 Ph: (717) 267-7169 | Nicholaos Kalathas, 112 N 7th St, Chambersburg, PA 17201-1720 Ph: (717) 267-7146 |
News Archive
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a preclinical trial for an H7N9 Avian Influenza VLP vaccine candidate ("H7 vaccine").
Imprivata®, Inc., the employee access management company and largest provider of healthcare single sign-on (SSO), today announced that it continues to see strong demand for its OneSign Platform solution from the healthcare industry's leading organizations.
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
Hops, the flower cones used in beer-making, are also found in dietary supplements designed to help treat post-menopausal symptoms and other conditions. Scientists are now investigating whether an extract from the plant could also help fend off breast cancer.
› Verified 9 days ago
Michael John Faretta Iii, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-267-7146 Fax: 717-267-7728 | |
Travis Daniel Watson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-267-7146 Fax: 717-267-7728 | |
Peter V Viriassov, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-267-7146 Fax: 717-267-7728 | |
Jon Bush, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-267-7146 Fax: 717-267-7728 | |
Christopher Andrew Rogers, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-267-3000 | |
Diane M Batt, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-267-7146 Fax: 717-267-7728 |